Allocations
Private equity major the Carlyle Group has closed its latest Asia-focused buyout fund – Carlyle Asia Growth Partners VII, which launched in April 2021 – with $950 million in capital commitments, according to a report by DealStreetAsia.
The report cites board documents from one of the fund’s limited partners as revealing that the new vehicle will focus on growth equity investments in fast-growing businesses primarily operating in the technology, business services, health care, consumer, media and retail industries.
The fund reportedly had an original target $1 billion in total, and according to a recent Securities and Exchange Commission filing, attracted
Hunter Point Capital has raised $2.66 billion for its debut fund, Hunter Point Capital Fund I, a GP stakes investment vehicle, exceeding its original target of $2.5 billion, according to a report by BuyoutsInsider.
LCM Partners has held the final close of the Credit Opportunities 4 Strategy, with total capital commitments of €4.1 billion across the commingled fund together with several separately managed accounts.Â
Ares Management Corporation, a global alternative investment manager, has launched the Ares Strategic Income Fund, a perpetual capital, continuously offered, non-traded business development company, with around $1.5 billion in initial investable capital.
Blackstone is aiming to raise $10 billion for the first vintage of its new direct lending fund, which launched in the first quarter of the year and will be marketed to both institutional and insurance clients, according to a report by BuyoutsInsider.
JP Morgan Growth Equity Partners has held final close of its inaugural Growth Equity Fund, with over $1 billion in aggregate capital commitments raised from a broad set of institutions, family offices and individual investors across the Americas, Europe and Asia, as well as JP Morgan.
O2 Investment Partners, a private equity firm investing in growth-oriented, privately-held businesses in the North American lower middle market, has held the final closing of O2 Investment Partners Fund IV (Fund IV) with $445 million in capital commitments.Â
European credit specialist AlbaCore Capital Group has priced AlbaCore Euro CLO V, its fifth Collateralised Loan Obligation (CLO) fund, at €347.6 million. AlbaCore Euro CLO V increases AlbaCore’s total value of CLO issuance to date from €1.9 billion to ~€2.3 billion.
Gilde Healthcare has raised €600 million in capital commitments for Gilde Healthcare Venture&Growth VI, a new investment fund which will focuse on fast growing companies developing solutions for better care at lower cost.
Forbion, a European life sciences venture capital firm, has raised €1.35 billion ($1.5 billion) for its two newest funds, bringing the firm’s total funds under management to €3 billion. Both exceeded their original target sizes and represent Forbion’s largest fundraising to date.
Both funds reached their hard caps of €750 million (Forbion Ventures Fund VI) and €600 million (Forbion Growth Opportunities Fund II) and are aimed at meeting the needs of distinct segments of the market.
The Forbion Ventures Fund VI is focused on building companies at an earlier stage of development and the Forbion Growth Opportunities Fund II supports
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
